The interplay between PEGylated nanoparticles and blood immune system
Advanced Drug Delivery Reviews · 2023-09 · 200 · 115044
DOI: 10.1016/j.addr.2023.115044 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2023-09. Verfasst von Chen Guo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, Liaoning, PR China. Hauptthemen laut MEDLINE: Liposomes, Nanoparticles. Die Arbeit wurde bisher 120-mal zitiert (Crossref) und nennt 292 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Liaoning Revitalization Talents Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
During the last two decades, an increasing number of reports have pointed out that the immunogenicity of polyethylene glycol (PEG) may trigger accelerated blood clearance (ABC) and hypersensitivity reaction (HSR) to PEGylated nanoparticles, which could make PEG modification counterproductive. These phenomena would be detrimental to the efficacy of the load and even life-threatening to patients. Consequently, further elucidation of the interplay between PEGylated nanoparticles and the blood immune system will be beneficial to developing and applying related formulations. Many groups have worked to unveil the relevance of structural factors, dosing schedule, and other factors to the ABC phenomenon and hypersensitivity reaction. Interestingly, the results of some reports seem to be difficult to interpret or contradict with other reports. In this review, we summarize the physiological mechanisms of PEG-specific immune response. Moreover, we speculate on the potential relationship between the induction phase and the effectuation phase to explain the divergent results in published reports. In addition, the role of nanoparticle-associated factors is discussed based on the classification of the action phase. This review may help researchers to develop PEGylated nanoparticles to avoid unfavorable immune responses based on the underlying mechanism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, Liaoning, PR China.
- School of Functional Food and Wine, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, Liaoning, PR China.
- Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, Liaoning, PR China. Electronic address: jxgou_syphu@163.com.
- Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, Liaoning, PR China. Electronic address: tanglab@126.com.
Förderung
- National Key Research and Development Program of China
- Liaoning Revitalization Talents Program
- National Natural Science Foundation of China
Zitieren
APA
Guo, C., Yuan, H., Wang, Y., Feng, Y., Zhang, Y., Yin, T., He, H., Gou, J., & Tang, X. (2023). The interplay between PEGylated nanoparticles and blood immune system. Advanced Drug Delivery Reviews, 200, 115044. https://doi.org/10.1016/j.addr.2023.115044
Vancouver
Guo C, Yuan H, Wang Y, Feng Y, Zhang Y, Yin T, et al. The interplay between PEGylated nanoparticles and blood immune system. Advanced Drug Delivery Reviews. 2023;200:115044. doi:10.1016/j.addr.2023.115044
BibTeX
@article{Guo2023,
author = {Guo, Chen and Yuan, Haoyang and Wang, Yuxiu and Feng, Yupeng and Zhang, Yu and Yin, Tian and He, Haibing and Gou, Jingxin and Tang, Xing},
title = {The interplay between PEGylated nanoparticles and blood immune system},
journal = {Advanced Drug Delivery Reviews},
year = {2023},
volume = {200},
pages = {115044},
doi = {10.1016/j.addr.2023.115044}
}
EUVIMED